PapersFlow Research Brief
COVID-19 and healthcare impacts
Research Guide
What is COVID-19 and healthcare impacts?
COVID-19 and healthcare impacts refers to the effects of the COVID-19 pandemic on cancer patients, healthcare systems, and clinical outcomes, including increased mortality, disruptions in surgery, delayed diagnosis and treatment, and changes in emergency department visits within oncology care.
This field encompasses 57,727 papers examining how COVID-19 affected cancer care, such as mortality rates and treatment delays. Studies document clinical characteristics of COVID-19 patients, many with cancer comorbidities, based on data from 1099 cases in China. Healthcare workers faced significant mental health challenges, with nurses and frontline staff in Wuhan reporting high psychological burden.
Topic Hierarchy
Research Sub-Topics
COVID-19 Mortality in Cancer Patients
This sub-topic assesses case fatality rates, risk factors, and prognostic models for COVID-19 in oncology populations. Researchers analyze comorbidities, treatments, and vaccination impacts.
Delayed Cancer Diagnosis During COVID-19
This sub-topic investigates pandemic-induced disruptions in screening and diagnostics leading to stage shifts. Researchers model excess cancers and long-term survival impacts.
Cancer Surgery Disruptions by COVID-19
This sub-topic evaluates postponements of oncologic surgeries and their effects on outcomes like recurrence. Researchers develop triage protocols and telemedicine integration.
Teleoncology and Virtual Cancer Care
This sub-topic explores remote monitoring, consultations, and chemotherapy management during lockdowns. Researchers assess efficacy, equity, and patient satisfaction.
Cancer Clinical Trials During Pandemics
This sub-topic addresses enrollment drops, protocol adaptations, and remote trial conduct amid COVID-19. Researchers evaluate data integrity and regulatory adaptations.
Why It Matters
The COVID-19 pandemic disrupted cancer care by delaying surgeries and diagnoses, leading to worse clinical outcomes for oncology patients. Richardson et al. (2020) analyzed 5700 hospitalized COVID-19 patients in New York City, finding that 27% required intensive care and comorbidities like cancer contributed to higher mortality. Lai et al. (2020) surveyed healthcare workers exposed to COVID-19, revealing that 50.4% reported depression, 44.6% anxiety, and 34.0% insomnia, with frontline nurses in Wuhan at greatest risk, which strained healthcare delivery during peak pandemic periods. These impacts highlight vulnerabilities in managing cancer alongside infectious disease outbreaks.
Reading Guide
Where to Start
'Clinical Characteristics of Coronavirus Disease 2019 in China' by Guan et al. (2020), as it provides foundational data on 1099 early cases, establishing baseline clinical features relevant to cancer patient vulnerabilities.
Key Papers Explained
Guan et al. (2020) in 'Clinical Characteristics of Coronavirus Disease 2019 in China' describes early patient data from 1099 cases, which Richardson et al. (2020) in 'Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area' extends to 5700 U.S. patients highlighting cancer comorbidities. Lai et al. (2020) in 'Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019' builds on this by addressing healthcare worker strain, while Ruan et al. (2020) in 'Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China' refines mortality predictors from Wuhan data.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Analysis of coagulation abnormalities by Tang et al. (2020) and vascular changes by Ackermann et al. (2020) point to ongoing needs for thrombosis management in cancer patients post-COVID. Recent emphasis remains on 2020-2023 data due to lack of new preprints.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Clinical Characteristics of Coronavirus Disease 2019 in China | 2020 | New England Journal of... | 30.8K | ✓ |
| 2 | Cancer statistics, 2023 | 2023 | CA A Cancer Journal fo... | 16.0K | ✓ |
| 3 | Presenting Characteristics, Comorbidities, and Outcomes Among ... | 2020 | JAMA | 9.8K | ✓ |
| 4 | Factors Associated With Mental Health Outcomes Among Health Ca... | 2020 | JAMA Network Open | 8.1K | ✓ |
| 5 | Estimating the global cancer incidence and mortality in 2018: ... | 2018 | International Journal ... | 7.5K | ✓ |
| 6 | Factors associated with COVID-19-related death using OpenSAFELY | 2020 | Nature | 6.5K | ✓ |
| 7 | First Case of 2019 Novel Coronavirus in the United States | 2020 | New England Journal of... | 6.3K | ✓ |
| 8 | Abnormal coagulation parameters are associated with poor progn... | 2020 | Journal of Thrombosis ... | 5.8K | ✓ |
| 9 | Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenes... | 2020 | New England Journal of... | 5.7K | ✓ |
| 10 | Clinical predictors of mortality due to COVID-19 based on an a... | 2020 | Intensive Care Medicine | 5.1K | ✓ |
Frequently Asked Questions
What were the clinical characteristics of early COVID-19 patients?
Guan et al. (2020) in 'Clinical Characteristics of Coronavirus Disease 2019 in China' extracted data from 1099 laboratory-confirmed cases, noting common symptoms and rapid spread from Wuhan. The study provides baseline data on patient demographics and outcomes essential for understanding pandemic effects on healthcare.
How did COVID-19 affect hospitalized patients with comorbidities like cancer?
Richardson et al. (2020) in 'Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area' reported that among 5700 cases, 88% had comorbidities, 27% needed intensive care, and mortality reached 11% early in the outbreak. Cancer was among factors linked to severe outcomes.
What mental health impacts did COVID-19 have on healthcare workers?
Lai et al. (2020) in 'Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019' found that 50.4% of surveyed workers experienced depression, 44.6% anxiety, and nurses in Wuhan faced the highest rates. Frontline exposure directly correlated with psychological burden.
How did COVID-19 influence cancer statistics and care systems?
Siegel et al. (2023) in 'Cancer statistics, 2023' compiled U.S. incidence and mortality data, reflecting pandemic disruptions like delayed treatments. The field covers 57,727 papers on oncology impacts including surgery postponements.
What role did coagulation play in COVID-19 prognosis?
Tang et al. (2020) in 'Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia' linked abnormal clotting to worse outcomes. This finding applies to vulnerable cancer patients with heightened thrombosis risks.
What are key clinical predictors of COVID-19 mortality?
Ruan et al. (2020) in 'Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China' identified factors from 150 cases that forecasted death. These predictors inform risk stratification in cancer care during pandemics.
Open Research Questions
- ? How did COVID-19-induced delays in cancer surgery affect long-term survival rates?
- ? What were the precise changes in emergency department visits for cancer patients during peak pandemic waves?
- ? How did COVID-19 management protocols alter clinical trial enrollment and outcomes in oncology?
- ? Which factors most amplified mortality risks for cancer patients coinfected with COVID-19?
- ? What adaptations in healthcare systems mitigated disruptions to cancer diagnosis during the pandemic?
Recent Trends
The field includes 57,727 works with growth data unavailable over five years, centered on 2020 studies like Guan et al. with 30,793 citations.
2020Siegel et al. in 'Cancer statistics, 2023' integrates pandemic effects into updated U.S. incidence figures.
2023No recent preprints or news coverage noted in the last 12 months.
Research COVID-19 and healthcare impacts with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching COVID-19 and healthcare impacts with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers